Prime Therapeutics Investor Relations Manager Salaries in Dallas | Comparably
Prime Therapeutics Claimed Company
Prime Therapeutics is an independent pharmacy benefit manager that primarily serves Blue Cross Blue Shield plans read more
EMPLOYEE
PARTICIPANTS
53
TOTAL
RATINGS
422
HR or Marketing? Claim Your Free Employer Account

Prime Therapeutics Investor Relations Manager Salaries in Dallas

The average Prime Therapeutics Investor Relations Manager in Dallas earns an estimated $88,025 annually. Prime Therapeutics' Investor Relations Manager compensation is $722 more than the US average for a Investor Relations Manager.

In Dallas, The Communications Department at Prime Therapeutics earns $407 more on average than the Finance Department.

Last updated a year ago.

$51k
$64k
$75k
$85k
$114k
$175k
$88,025
Average Compensation
$88,025
avg. base

Investor Relations Manager Salaries at Prime Therapeutics

In Dallas, Investor Relations Managers earn $5,152 more than Editors.

Editor
$83k*
* estimated salary

Compensation at Prime Therapeutics by Department

In Dallas, The Communications Department averages $407 more than the Finance Department, and $12,179 less than the Design Department

Design
$92,515 Avg. total comp.
+$12k
Communications
$80,336 Avg. total comp.
Finance
$79,929 Avg. total comp.
-$407

Investor Relations Manager Compensation by Gender (All Companies)

The average female Investor Relations Manager at companies similar size to Prime Therapeutics reported making $113,250, while the average male Investor Relations Manager at similar sized companies reported making $68,100.

Investor Relations Manager Compensation by Ethnicity (All Companies)

The average Caucasian Investor Relations Manager at companies similar size to Prime Therapeutics reported making $102,750, while the average African American/Black Investor Relations Manager at similar sized companies reported making $76,200.

How Investor Relations Managers at Prime Therapeutics Rate Their Compensation

The majority of Investor Relations Managers at Prime Therapeutics believe they're compensated fairly. 100% of Investor Relations Managers at Prime Therapeutics say they receive annual bonuses, and the vast majority (77%) are satisfied with their benefits. See more compensation ratings at Prime Therapeutics

×
Rate your company